Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-16

Clinical Trial Update: Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease

View source ↗

Summary

A clinical trial investigating sensory filtering in the human basal ganglia as a mechanism of Parkinson disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Parkinson Disease | Status: RECRUITING